NL-OMON27217
Recruiting
Not Applicable
A decision aid for the treatment of Benign Prostatic Hyperplasia: a prospective cohort study to investigate the effect
Not provided0 sites200 target enrollmentTBD
ConditionsDA BPH
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- DA BPH
- Sponsor
- Not provided
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •New patient with a LUTS caused by benign prostatic hyperplasia who have the choice between:
- •\- waiting OR start medication
Exclusion Criteria
- •\-absolute operation indication (example: persistent urinary retention)
- •\- speak not good enough dutch to understand the DA or questionnary
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A Clinical Study to evaluate efficacy of Unani Formulation in Benign Prostatic HyperplasiaHealth Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsCTRI/2023/09/057510Ayurvedic and Unani Tibbia College Hospital40
Completed
Not Applicable
aser enucleation of the prostate for benign prostatic hyperplasiaN40Hyperplasia of prostateDRKS00008206Asklepios Klinik Barmbek110
Active, not recruiting
Phase 1
STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyEUCTR2004-000193-31-GBniversity College London12,000
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Not yet recruiting
Phase 1
A real world study on the treatment of prostate cancer by integrated Chinese and Western medicineProstate cancerITMCTR2200006847Guangdong Provincial Hospital of Chinese Medicine